A coronavirus test that attracted some criticism for its accuracy is apparently on the money almost all of the time. On Wednesday, Abbott Laboratories (NYSE:ABT) announced that interim clinical data indicates that its ID NOW COVID-19 test correctly identified positive cases in 95% of instances.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,